| Two year, degree-granting fellowship, in partnership with The University of Texas at Austin College of Pharmacy. This two-year fellowship will prepare talented individuals with a strong interest in pursuing a Health Economics and Outcomes Research (HEOR) career within managed care, pharmaceutical industry, consulting, or academia. The fellowship will be based at Baylor Scott & White Health and will allow the trainee to obtain a Master of Science in Pharmaceutical Sciences, Health Outcomes and Pharmacy Practice degree from The University of Texas at Austin College of Pharmacy upon completion of the required didactic courses and successful thesis defense. Fellowship Goals and Objectives - Expand the fellow’s knowledge base through Master’s level coursework within the Health Outcomes Division at the UT Austin College of Pharmacy in pharmacoeconomics, epidemiology, statistics, pharmaceutical markets, health policy, leadership, business strategy, management, marketing, and finance.
- Provide training and experience in utilizing medical/pharmacy claims and EMR data in protocol development, data collection, management, and analysis, effective presentation of results, and medical communications.
- Apply learned HEOR concepts and appropriate analytical methods in conducting retrospective database studies, prospective research studies, and economic modeling
- Develop a functional knowledge of statistical software: SAS, SQL, STATA, R
- Gain a holistic perspective of different healthcare stakeholders’ strategy:
- Integrated Delivery Systems (IDS) and Accountable Care Organizations (ACO) and National Payers – gain valuable work experience by engaging in daily IDS & ACO meetings and designing value based evaluations to solve real world problems encountered as Health Systems, ACOs, and National Payers evolve from the fee for service environment to a value based population health model
- Managed Care – Cost containment (Quality & Outcome Metrics), Innovative Pricing Strategies (Value-based Pricing), P&T, Formulary Development, Pharmacy vs. Medical Benefit (Specialty, Biologics & Biosimilars)
- Industry – Value proposition via real-world evidence generation, pricing and contracting (Specialty, Biologics & Biosimilars)
- Contribute to body of literature in the development and publication of abstracts, posters and manuscripts as well as attending professional meetings and seminars.
|
